Article
Phenotypic Approaches to Identify Inhibitors of B Cell Activation.
Journal of biomolecular screening - 1 Aug 2015
Rex Elizabeth B, Kim Suzie, Wiener Jake, Rao Navin L, Milla Marcos E, DiSepio Daniel
Abstract excerpt
An EPIC label-free phenotypic platform was developed to explore B cell receptor (BCR) and CD40R-mediated B cell activation. The phenotypic assay measured the association of RL non-Hodgkin's lymphoma B cells expressing lymphocyte function-associated antigen 1 (LFA-1) to intercellular adhesion molecule 1 (ICAM-1)-coated EPIC plates. Anti-IgM (immunoglobulin M) mediated BCR activation elicited a response that was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
